Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upexi (UPXI) Change in Accured Expenses (2021 - 2025)

Historic Change in Accured Expenses for Upexi (UPXI) over the last 5 years, with Q4 2025 value amounting to $639755.0.

  • Upexi's Change in Accured Expenses rose 6160.69% to $639755.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $5.8 million, marking a year-over-year increase of 124053.43%. This contributed to the annual value of $2.9 million for FY2025, which is 40351.59% up from last year.
  • According to the latest figures from Q4 2025, Upexi's Change in Accured Expenses is $639755.0, which was up 6160.69% from $2.2 million recorded in Q3 2025.
  • In the past 5 years, Upexi's Change in Accured Expenses ranged from a high of $2.4 million in Q2 2025 and a low of -$2.4 million during Q4 2023
  • Over the past 5 years, Upexi's median Change in Accured Expenses value was $389874.0 (recorded in 2024), while the average stood at $251163.8.
  • In the last 5 years, Upexi's Change in Accured Expenses crashed by 196189.11% in 2022 and then surged by 54584.0% in 2025.
  • Quarter analysis of 5 years shows Upexi's Change in Accured Expenses stood at -$979383.0 in 2021, then skyrocketed by 308.83% to $2.0 million in 2022, then plummeted by 217.44% to -$2.4 million in 2023, then soared by 116.48% to $395871.0 in 2024, then surged by 61.61% to $639755.0 in 2025.
  • Its Change in Accured Expenses was $639755.0 in Q4 2025, compared to $2.2 million in Q3 2025 and $2.4 million in Q2 2025.